This organization files Form 990, which has no section for application policy. Its filings cannot say either way.
The latest filing we hold carries no statement about applications. That is not the same as closed: public-charity Form 990s have no field for it, and many foundations leave the section blank.
No parsed e-filed return is on record for this organization yet, so year-by-year financials are not available.
Asset, income and revenue figures come from the IRS master file (the IRS Exempt Organizations Business Master File), a coarse annual extract. Year-by-year figures appear once the organization's e-filed returns are in the database.
Recipient focus areas
Where recipients are
Based on the 75% of grant rows we could match to an organization record. The rest stay as reported. The IRS assigns the NTEE category when it grants exemption. It often reflects the original filing, not today's giving.
| Recipient | Purpose | Amount | Year | Source |
|---|---|---|---|---|
| MEMORIAL SLOAN-KETTERING CANCER CENTER 21 | CANCER RESEARCH | $250,000 | 2021 | |
Recipients are shown as the funder wrote them on the return. A recipient with a link was matched to an organization record; the rest stay as reported and are never guessed.
| 2023 LAST MILE AWARD |
| $150,000 |
| 2023 |
| UNIVERSITY OF TX MD ANDERSON CANCER CENTER | CANCER RESEARCH | $100,000 | 2022 |
| CLEVELAND CLINIC PHILANTHROPY INSTITUTECLEVELAND, OH | TO SUPPORT SARCOMA RESEARCH | $86,437 | 2023 |
| CLEVELAND CLINICPHILANTHROPY INSTITUTE | CANCER RESEARCH | $72,470 | 2021 |
| SITEMAN CANCER CENTERSTLOUIS, MO | TO SUPPORT SARCOMA RESEARCH | $64,972 | 2023 |
| CLEVELAND CLINIC PHILANTHROPY INSTITUTECLEVELAND, OH | TO SUPPORT SARCOMA RESEARCH | $57,035 | 2024 |
| CLEVELAND CLINICPHILANTROPHY INSTITUTE | CANCER RESEARCH | $53,180 | 2022 |
| CLEVELAND CLINIC 2020 | CANCER RESEARCH | $50,233 | 2020 |
| HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY | CANCER RESEARCH | $50,000 | 2021 |
| DANA-FARBER CANCER INSTITUTE INCBOSTON, MA | SARCOMA FOUNDATION OF AMERICA RESEARCH AWARD | $50,000 | 2024 |
| THE REGENTS OF THE UC SAN FRANSISCO | CANCER RESEARCH | $50,000 | 2021 |
| THE CHILDREN'S HOSPITAL OF PHILADELPHIA | CANCER RESEARCH | $50,000 | 2021 |
| JOHNS HOPKINS UNIVERSITYCHICAGO, IL | CANCER RESEARCH GRANT | $50,000 | 2023 |
| DANA-FARBER CANCER INSTITUTE INC | CANCER RESEARCH | $50,000 | 2022 |
| UNIVERSITY OF MASSACHUSETTS CHAN MEDICALWORCESTER, MA | CANCER RESEARCH GRANT | $50,000 | 2023 |
| DANA-FARBER CANCER INSTITUTE INC | CANCER RESEARCH | $50,000 | 2021 |
| ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | CANCER RESEARCH | $50,000 | 2022 |
| THE NATIONAL CANCER INSTITUTEBETHESDA, MD | CANCER RESEARCH GRANT | $50,000 | 2023 |
| UNIV OF TX MD ANDERSON CANCER CENTERHOUSTON, TX | CANCER RESEARCH GRANT | $50,000 | 2023 |
| WILLIAM MARSH RICE UNIVERSITY | CANCER RESEARCH | $50,000 | 2022 |
| UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER | CANCER RESEARCH | $50,000 | 2022 |
| UNIVERSITY OF COLORADO CANCER CENTER | CANCER RESEARCH | $50,000 | 2021 |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELESLOS ANGELES, CA | TECHNOBLADE MEMORIAL RESEARCH AWARD | $50,000 | 2024 |
| MAYO CLINICMINNEAPOLIS, MN | MICHAEL PEDRICK MEMORIAL RESEARCH AWARD | $50,000 | 2024 |
Nearest by size, location and giving pattern in the database. Geography weighs heavily. Treat it as a starting list, not a ranking of fit.
Form 990 · FY2023 · period ending Dec 31, 2023IRS bulk XML
Filing id 202433199349312458
Form 990 · FY2022 · period ending Dec 31, 2022
Filing id 202342099349301124
Form 990 · FY2021 · period ending Dec 31, 2021
Filing id 202233089349300028
Form 990 · FY2020 · period ending Dec 31, 2020
Filing id 202112859349300306
Form 990 · FY2018 · period ending Dec 31, 2018
Filing id 201932949349300208
Form 990 · FY2017 · period ending Dec 31, 2017
Filing id 201812849349300801
Form 990 · FY2016 · period ending Dec 31, 2016
Filing id 201743039349300124
Form 990 · FY2015 · period ending Dec 31, 2015
Filing id 201642819349300529
IRS filings are the source for every fact on this page. Nothing a model writes is ever a source; it can only point at a row here.